Global Vacuum-Assisted Biopsy Devices Market 2024-2030
  • CHOOSE LICENCE TYPE
Consulting Services
    How will you benefit from our consulting services ?

Global Vacuum-Assisted Biopsy Devices Market 2024-2030

Last Updated:  Apr 25, 2025 | Study Period: 2024-2030

VACUUM-ASSISTED BIOPSY DEVICES MARKET

 

INTRODUCTIONVACUUM-ASSISTED BIOPSY DEVICES MARKET

A vacuum assisted biopsy (VAB) of the breast is a method of obtaining a sample of aberrant breast tissue to examine under a microscope. The procedure is also known as a mammotome biopsy. A vacuum core biopsy and a minimally invasive breast biopsy (MIBB).

 

A procedure that removes a small sample of tissue from the breast. An imaging device is used to guide a hollow probe coupled to a vacuum apparatus. The probe is placed through a tiny cut in the numbed skin of the breast.The VAB employs a specialised tool that uses vacuum or suction to remove more tissue. This provides more information about the irregularity in their breast tissue. 

 

VACUUM-ASSISTED BIOPSY DEVICES MARKET SIZE AND FORECAST

 

infographic: Vacuum-Assisted Biopsy Devices Market , Vacuum-Assisted Biopsy Devices Market Size, Vacuum-Assisted Biopsy Devices Market Trends, Vacuum-Assisted Biopsy Devices Market Forecast, Vacuum-Assisted Biopsy Devices Market Risks, Vacuum-Assisted Biopsy Devices Market Report, Vacuum-Assisted Biopsy Devices Market Share

 

The Global Vacuum-assisted Biopsy Devices Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

 

VACUUM-ASSISTED BIOPSY DEVICES MARKETNEW PRODUCT LAUNCH

Devicor Introduces New Tetherless Vacuum-Assisted Biopsy System The FDA has approved the Mammotome Elite Biopsy System, which includes TruVac Vacuum Technology. Devicor Medical Products Inc. announced the commercial launch of the Mammotome elite Biopsy System, the only tetherless single insertion, multiple sample, vacuum-assisted biopsy (VAB) equipment with unique TruVac vacuum technology.

 

Unlike other devices that rely on automated syringes, elite has a vacuum that produces approximately the same suction power as the classic Mammotome VAB system, allowing the device to capture big, high-quality tissue samples. 

 

The Mammotome Elite Biopsy System will be utilised in ultrasound-guided breast and axillary lymph node biopsies to aid in the detection and treatment of breast cancer. Devicor acquired 510(k) authorization from the US Food and Drug Administration (FDA) in March to employ the system on patients.  In Europe, the product has also acquired CE certification.

 

The Mammotome elite system contains a reusable holster, charging base, and single-patient-use disposable 13-gauge probe with a bladed insertion tip. This tip is designed to move easily through tissue while allowing physicians to maintain control of the needle even in problematic dense breast tissue. Elite's innovative lightweight ergonomic design gives improved control for precise needle placement and effortless insertion.

 

VACUUM-ASSISTED BIOPSY DEVICES MARKETCOMPANY PROFILE

 

THISVACUUM-ASSISTED BIOPSY DEVICES MARKETREPORT WILL ANSWER FOLLOWING QUESTIONS

  1. How many  Vacuum-assisted Biopsy Devices are manufactured per annum globally? Who are the sub-component suppliers in different regions?
  2. Cost breakup of a Global  Vacuum-assisted Biopsy Devices and key vendor selection criteria
  3. Where is the  Vacuum-assisted Biopsy Devices manufactured? What is the average margin per unit?
  4. Market share of Global  Vacuum-assisted Biopsy Devices market manufacturers and their upcoming products
  5. Cost advantage for OEMs who manufacture Global  Vacuum-assisted Biopsy Devices in-house
  6. key predictions for next 5 years in Global  Vacuum-assisted Biopsy Devices market
  7. Average B-2-B  Vacuum-assisted Biopsy Devices market price in all segments
  8. Latest trends in  Vacuum-assisted Biopsy Devices market, by every market segment
  9. The market size (both volume and value) of the  Vacuum-assisted Biopsy Devices market in 2024-2030 and every year in between?
  10. Production breakup of  Vacuum-assisted Biopsy Devices market, by suppliers and their OEM relationship

 

Sl noTopic
1Market Segmentation
2Scope of the report
3Abbreviations
4Research Methodology
5Executive Summary
6Introduction
7Insights from Industry stakeholders
8Cost breakdown of Product by sub-components and average profit margin
9Disruptive innovation in the Industry
10Technology trends in the Industry
11Consumer trends in the industry
12Recent Production Milestones
13Component Manufacturing in US, EU and China
14COVID-19 impact on overall market
15COVID-19 impact on Production of components
16COVID-19 impact on Point of sale
17Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
18Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
19Market Segmentation, Dynamics and Forecast by Application, 2024-2030
20Market Segmentation, Dynamics and Forecast by End use, 2024-2030
21Product installation rate by OEM, 2023
22Incline/Decline in Average B-2-B selling price in past 5 years
23Competition from substitute products
24Gross margin and average profitability of suppliers
25New product development in past 12 months
26M&A in past 12 months
27Growth strategy of leading players
28Market share of vendors, 2023
29Company Profiles
30Unmet needs and opportunity for new suppliers
31Conclusion
32Appendix